Literature DB >> 10024914

Pyrin/marenostrin mutations in familial Mediterranean fever.

D R Booth1, J D Gillmore, S E Booth, M B Pepys, P N Hawkins.   

Abstract

Familial Mediterranean fever (FMF) is an inherited inflammatory disease that is frequently complicated by reactive systemic (AA) amyloidosis. It is principally recognized in certain Mediterranean populations, and the diagnosis depends on clinical features. Four mutations strongly linked to FMF have lately been identified in a gene encoding a novel protein that has been named pyrin or marenostrin. We studied 27 consecutive patients of varied ethnic origin, including an English man, who had classical, probable or possible FMF. Pyrin/marenostrin genotypes were determined, and AA amyloidosis was sought using serum amyloid P component scintigraphy. Among the 23 patients with classical or probable FMF, 17 were homozygotes or compound heterozygotes for pyrin/marenostrin mutations, and in five, only single allele mutations were identified. Two new mutations, T6811 and delta M694, were discovered in addition to the four described previously. No mutations were identified in three of the four patients with possible FMF. Nine patients had AA amyloidosis, but this association was not restricted to any particular genotype. Most patients with FMF have mutations in both pyrin/marenostrin alleles, and genotyping at this locus is a valuable diagnostic test. Unidentified second mutations are likely to occur in FMF patients who have apparently solitary mutations, and therefore genotype results must be interpreted in conjunction with the clinical picture.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10024914     DOI: 10.1093/qjmed/91.9.603

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  15 in total

1.  Homology modeling provides insights into the binding mode of the PAAD/DAPIN/pyrin domain, a fourth member of the CARD/DD/DED domain family.

Authors:  Tong Liu; Ana Rojas; Yuzhen Ye; Adam Godzik
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

2.  Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population.

Authors:  I Aksentijevich; Y Torosyan; J Samuels; M Centola; E Pras; J J Chae; C Oddoux; G Wood; M P Azzaro; G Palumbo; R Giustolisi; M Pras; H Ostrer; D L Kastner
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 3.  Familial Mediterranean fever.

Authors:  Fatos Onen
Journal:  Rheumatol Int       Date:  2005-11-10       Impact factor: 2.631

4.  As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio.

Authors:  Ahmet Ahsen; Memnune Sena Ulu; Seref Yuksel; Kasım Demir; Mukremin Uysal; Mujgan Erdogan; Gursel Acarturk
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

5.  The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.

Authors:  F Yalçinkaya; N Cakar; B Acar; E Tutar; H Güriz; A H Elhan; S Oztürk; A Kansu; E Ince; S Atalay; N Girgin; U Doğru; D Aysev; M Ekim
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 2.631

6.  The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever.

Authors:  Nuran Turkcapar; Timur Tuncali; Sim Kutlay; Basak Yalcin Burhan; Gulay Kinikli; Sehsuvar Erturk; Murat Duman
Journal:  Rheumatol Int       Date:  2006-11-11       Impact factor: 2.631

7.  Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever.

Authors:  C Cazeneuve; H Ajrapetyan; S Papin; F Roudot-Thoraval; D Geneviève; E Mndjoyan; M Papazian; A Sarkisian; A Babloyan; B Boissier; P Duquesnoy; J C Kouyoumdjian; E Girodon-Boulandet; G Grateau; T Sarkisian; S Amselem
Journal:  Am J Hum Genet       Date:  2000-10-03       Impact factor: 11.025

8.  The spectrum of FMF mutations and genotypes in the referrals to molecular genetic laboratory at Kirikkale University in Turkey.

Authors:  Aysen Gunel-Ozcan; Derya Beyza Sayin; Emine Dibek Misirlioğlu; Sefa Güliter; Fahri Yakaryilmaz; Cuneyt Ensari
Journal:  Mol Biol Rep       Date:  2008-04-04       Impact factor: 2.316

9.  MEFV gene mutations spectrum among Lebanese patients referred for Familial Mediterranean Fever work-up: experience of a major tertiary care center.

Authors:  Amira S Sabbagh; Mona Ghasham; Rabab Abdel Khalek; Layal Greije; Dina M R Shammaa; Ghazi S Zaatari; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2007-06-14       Impact factor: 2.316

10.  Gastric changes following colchicine therapy in patients with FMF.

Authors:  Wael Ismail Al-Daraji; Riham M W Al-Mahmoud; Mohammed Ilyas
Journal:  Dig Dis Sci       Date:  2007-12-15       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.